TABLE 2.

In vitro antimicrobial activities of FQ-CLR combinations against clinically isolated MAC strains

FQ-CLRNo. (%) of isolates showing interactiona:
SynergismIndifferenceAntagonism
MXF-CLR (n = 43)1 (2)19 (45)23 (53) [1 (2)]
GAT-CLR (n = 42)1 (2)17 (41)24 (57) [1 (2)]
LVX-CLR (n = 42)0 (0)18 (43)24 (57) [0 (0)]
  • a Synergism, FIC ≤ 0.5; indifference, 0.5 < FIC ≤ 2.0; antagonism, FIC > 2.0 [FIC > 4.0].